Articles with public access mandates - Joel LavineLearn more
Not available anywhere: 4
The intersection of nonalcoholic fatty liver disease and obesity
JA Woo Baidal, JE Lavine
Science translational medicine 8 (323), 323rv1-323rv1, 2016
Mandates: US National Institutes of Health
Enteric‐coated cysteamine for the treatment of paediatric non‐alcoholic fatty liver disease
R Dohil, S Schmeltzer, BL Cabrera, T Wang, J Durelle, KB Duke, ...
Alimentary pharmacology & therapeutics 33 (9), 1036-1044, 2011
Mandates: US National Institutes of Health
The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects
R Dohil, L Meyer, S Schmeltzer, BL Cabrera, JE Lavine, SA Phillips
The Journal of pediatrics 161 (4), 639-645. e1, 2012
Mandates: US National Institutes of Health
Caring for children with NAFLD and navigating their care into adulthood
AA Mencin, R Loomba, JE Lavine
Nature Reviews Gastroenterology & Hepatology 12 (11), 617-628, 2015
Mandates: US National Institutes of Health
Available somewhere: 82
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
AJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ...
New England Journal of Medicine 362 (18), 1675-1685, 2010
Mandates: US National Institutes of Health
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
BA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ...
The Lancet 385 (9972), 956-965, 2015
Mandates: US National Institutes of Health
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial
JE Lavine, JB Schwimmer, ML Van Natta, JP Molleston, KF Murray, ...
Jama 305 (16), 1659-1668, 2011
Mandates: US National Institutes of Health
Endpoints and clinical trial design for nonalcoholic steatohepatitis
AJ Sanyal, EM Brunt, DE Kleiner, KV Kowdley, N Chalasani, JE Lavine, ...
Hepatology 54 (1), 344-353, 2011
Mandates: US National Institutes of Health
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease
BA Neuschwander‐Tetri, JM Clark, NM Bass, ML Van Natta, ...
Hepatology 52 (3), 913-924, 2010
Mandates: US National Institutes of Health
Heritability of nonalcoholic fatty liver disease
JB Schwimmer, MA Celedon, JE Lavine, R Salem, N Campbell, ...
Gastroenterology 136 (5), 1585-1592, 2009
Mandates: US National Institutes of Health
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis
AN Tang, J Tan, M Sun, G Hamilton, M Bydder, T Wolfson, AC Gamst, ...
Radiology 267 (2), 422-431, 2013
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
R Loomba, M Abraham, A Unalp, L Wilson, J Lavine, E Doo, NM Bass, ...
Hepatology 56 (3), 943-951, 2012
Mandates: US National Institutes of Health
Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease
JB Schwimmer, PE Pardee, JE Lavine, AK Blumkin, S Cook
Circulation 118 (3), 277-283, 2008
Mandates: US National Institutes of Health
Relaxation effects in the quantification of fat using gradient echo imaging
M Bydder, T Yokoo, G Hamilton, MS Middleton, AD Chavez, ...
Magnetic resonance imaging 26 (3), 347-359, 2008
Mandates: US National Institutes of Health
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
ZM Younossi, R Loomba, QM Anstee, ME Rinella, E Bugianesi, ...
Hepatology 68 (1), 349-360, 2018
Mandates: US National Institutes of Health
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD—clinicopathologic correlations from the nonalcoholic …
EM Brunt, DE Kleiner, LA Wilson, A Unalp, CE Behling, JE Lavine, ...
Hepatology 49 (3), 809-820, 2009
Mandates: US National Institutes of Health
Nonalcoholic Fatty Liver Disease: Diagnostic and Fat-Grading Accuracy of Low-Flip-Angle Multiecho Gradient-Recalled-Echo MR Imaging at 1.5 T1
T Yokoo, M Bydder, G Hamilton, MS Middleton, AC Gamst, T Wolfson, ...
Radiology 251 (1), 67-76, 2009
Mandates: US National Institutes of Health
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
ZM Younossi, R Loomba, ME Rinella, E Bugianesi, G Marchesini, ...
Hepatology 68 (1), 361-371, 2018
Mandates: US National Institutes of Health
Advances in pediatric nonalcoholic fatty liver disease
R Loomba, CB Sirlin, JB Schwimmer, JE Lavine
Hepatology 50 (4), 1282-1293, 2009
Mandates: US National Institutes of Health
Association of histologic disease activity with progression of nonalcoholic fatty liver disease
DE Kleiner, EM Brunt, LA Wilson, C Behling, C Guy, M Contos, ...
JAMA network open 2 (10), e1912565, 2019
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program